To further assess the diagnostic potential of APLP1+ EVs for brain diseases, we evaluated their expression in the blood of patients with glioblastoma multiforme (GBM) exhibiting EGFR and EGFRviii expression (Fig. 7A). Here, EGFR is linked to glioblastoma.